SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-10
👔
Arcutis Biotherapeutics, Inc.
@ARQT_InsiderForm 4 Filing: Welgus Howard G. Acquires (Grant) shares of $ARQT
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Arcutis Biotherapeutics, Inc.
Ticker: $ARQT
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-05
Shares: 5,778
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Welgus Howard G., holds the title of Director at Arcutis Biotherapeutics, Inc..
On 2026-06-05, the insider transacted 5,778 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Welgus Howard G. (Director) was granted $0 of $ARQT
Post-Transaction Position: 38,378 shares
SEC Accession No: 0001628280-26-042044 (CIK: 1801050)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.